Skip to main content
. 2022 Oct 17;38(7):2069–2076. doi: 10.1007/s00467-022-05752-6

Fig. 3.

Fig. 3

Initial evaluation based on clinical manifestations of cSLE. Ig, immunoglobulin; ANA, antinuclear antibodies; anti-dsDNA, anti-double-strand DNA antibodies; DNASE1L3, deoxyribonuclease 1 like 3; PRKC δ, protein kinase C δ